Cybin, Inc. (TSE:CYBN) has released an update.
Cybin Inc., a pioneering biopharmaceutical company in the psychedelic treatment space, will be featured at the TD Cowen 44th Annual Health Care Conference, with its CEO Doug Drysdale presenting on March 4, 2024. The event will be webcast live and later available on the company’s investor relations page. Cybin is actively developing innovative treatments for mental health disorders, with CYB003 and CYB004 as its leading investigational compounds.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
